Live Breaking News & Updates on Induced Hyperalgesia

Stay updated with breaking news from Induced hyperalgesia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Trevena : Reports Fourth Quarter 2023 Results and Provides Corporate Update - Form 8-K -April 01, 2024 at 06:12 am EDT

Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update

TRV045, novel S1P receptor modulator for chronic pain and epilepsy, advances toward important. ....

United States , Carrie Bourdow , Bob Yoder , Trevena Inc , Company Annual Report On Form , Company Contact , National Institutes Of Health , Epilepsy Therapy Screening Program , Trevena Medical Information Contact Center , Lifesci Advisors , Exchange Commission , Trevena Reports Fourth Quarter , Provides Corporate , Recent Corporate , Supported Epilepsy Therapy Screening Program , Fourth Quarter , Nobel Prize , National Institutes , Investigational New Drug Application , Important Safety Information , Induced Hyperalgesia , Private Securities Litigation Reform Act , Risk Factors , Annual Report , Quarterly Reports , Sci Advisors ,

Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update

TRV045, novel S1P receptor modulator for chronic pain and epilepsy, advances toward important milestones in both non-clinical and clinical studies. ....

United States , Carrie Bourdow , Bob Yoder , Company Contact , Epilepsy Therapy Screening Program , Company Annual Report On Form , National Institutes Of Health , Lifesci Advisors , Exchange Commission , Trevena Inc , Trevena Medical Information Contact Center , Recent Corporate , Supported Epilepsy Therapy Screening Program , Fourth Quarter , Nobel Prize , National Institutes , Investigational New Drug Application , Important Safety Information , Induced Hyperalgesia , Private Securities Litigation Reform Act , Risk Factors , Annual Report , Quarterly Reports , Sci Advisors , Chief Business , Months Ended Dec ,